Autoimmune hepatitis is a chronic liver disease in which the immune system mistakenly attacks liver cells. Early diagnosis and treatment can control inflammation and prevent progressive scarring.GastroDoxs GutDefense Pathway™ helps patients recognize warning signs, understand causes, and seek timely evaluation and care confidently.
Essential facts about autoimmune hepatitis
No. It is an autoimmune liver disease, not a viral infection, and it cannot spread from one person to another.
Yes. Many people are diagnosed after elevated liver enzymes are found during routine testing or evaluation for another condition.
Yes. Immune-suppressing medicines can reduce inflammation, improve liver tests, and prevent or sometimes reverse liver damage when treatment begins early.
Your guardians. GastroDoxs GutGuardians™ is an elite team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.
Your complete arc. The GastroDoxs GutDefense Pathway™ is your complete operational framework - a structured patient journey that connects digestive health awareness, education, screening, prevention, diagnosis, and treatment into one seamless board-certified gastroenterologist-commanded arc, guided by expert GI care from your first concern to lasting gut health for life.
How the condition develops and affects the body
For reasons that are not fully understood, immune cells and antibodies react against liver tissue, causing inflammation and cell injury.
Certain inherited traits may increase susceptibility, while environmental triggers such as infections or medicines may help start an abnormal immune response in some people.
Untreated or uncontrolled inflammation can progress from fibrosis to cirrhosis. Significant damage may be present even when symptoms are mild.
Normal liver enzymes and controlled inflammation indicate remission, but the immune process can return. Many patients need long-term treatment or monitoring.
What different patterns may suggest
| Pattern | Why It Matters | Possible Next Step |
|---|---|---|
| Elevated liver enzymes with few or no symptoms | Autoimmune hepatitis can be silent and may resemble several other liver conditions | Complete a structured liver evaluation rather than repeating tests alone |
| Fatigue, joint pain, nausea, or right upper abdominal discomfort | May accompany immune-driven liver inflammation but is not diagnostic | Discuss liver tests and other possible causes |
| Jaundice, dark urine, pale stool, or marked itching | Can indicate significant hepatitis or impaired bile processing | Arrange prompt medical assessment |
| Confusion, vomiting blood, black stool, severe swelling, or fainting | May signal liver failure or portal-hypertension complications | Seek emergency care |
Common causes, triggers, and risk factors
The immune system mistakenly identifies liver cells as harmful and attacks them. The exact reason this reaction begins is not fully known.
Autoimmune hepatitis is more common in people with certain immune-related genetic patterns, but it is not inherited in a simple or predictable way.
Infections and some medicines may trigger liver injury that resembles or activates autoimmune hepatitis in susceptible people. A full medication and supplement review is essential.
Autoimmune thyroid disease, celiac disease, inflammatory bowel disease, type 1 diabetes, and other autoimmune disorders occur more often in people with autoimmune hepatitis.
How clinicians identify the condition and its cause
ALT, AST, bilirubin, alkaline phosphatase, clotting tests, and other labs show the pattern and severity of liver injury. Immunoglobulin G is often elevated.
Tests may include antinuclear antibody, smooth-muscle antibody, liver-kidney microsomal antibody, and other markers. Negative antibodies do not completely rule out the disease.
Clinicians review viral hepatitis, fatty liver disease, alcohol, medicines, supplements, Wilson disease, bile-duct conditions, and other causes that can look similar.
A biopsy is usually needed to confirm the diagnosis, grade inflammation, assess fibrosis, and distinguish autoimmune hepatitis from overlapping or medication-related liver injury.
No single blood test diagnoses autoimmune hepatitis. Diagnosis uses the complete clinical pattern and generally includes liver biopsy.
GastroDoxs evaluates unexplained liver inflammation, autoimmune markers, elevated immunoglobulin G, abnormal liver tests, fibrosis risk, and suspected autoimmune hepatitis.
Do not stop steroids or immune-suppressing medicine suddenly or change the dose based only on how you feel. Liver inflammation can return before symptoms become obvious.
Common questions about immune-driven liver inflammation, diagnosis, treatment, remission, and monitoring
Autoimmune hepatitis is a chronic disease in which the immune system attacks liver cells, causing inflammation and possible liver damage.
The exact cause is unknown. Genetic susceptibility may combine with environmental triggers, infections, or medicines to start an abnormal immune reaction.
Symptoms may include fatigue, joint pain, nausea, poor appetite, right upper abdominal discomfort, itching, dark urine, pale stool, or jaundice. Some people have no symptoms.
Diagnosis uses medical history, liver tests, immunoglobulin G, autoantibodies, tests for other liver diseases, imaging, and usually a liver biopsy.
It is generally controlled rather than permanently cured. Many people reach remission with treatment, but relapse can occur and long-term monitoring is needed.
It can be serious if inflammation is severe or untreated. It may lead to cirrhosis, liver failure, bleeding complications, or the need for liver transplantation.
It can affect anyone but is more common in females and in people with other autoimmune diseases. Both children and adults can develop it.
Yes. Ongoing inflammation can cause progressive fibrosis and cirrhosis. Early treatment and sustained control reduce this risk.
Treatment usually includes a corticosteroid and often another immune-suppressing medicine. The goal is to normalize liver inflammation using the lowest effective long-term treatment.
Yes. Remission means symptoms improve and liver tests show controlled inflammation. Some people can later attempt medication withdrawal under close specialist supervision, but relapse is common.
Genetics can influence susceptibility, but autoimmune hepatitis is not usually passed from parent to child in a simple pattern. Most relatives will not develop the disease.
Yes. Children can develop autoimmune hepatitis, including a less common type associated with liver-kidney microsomal antibodies. Pediatric liver care is important.
Flares may follow medication reduction or withdrawal, missed doses, immune changes, or may occur without a clear trigger. Some drugs can also cause liver injury that resembles autoimmune hepatitis.
Yes. Fatigue is common, but it does not always match the level of liver inflammation. Persistent fatigue should be assessed for medication effects, anemia, thyroid disease, sleep problems, and other causes.
Monitoring may include ALT, AST, bilirubin, immunoglobulin G, blood counts, medication-safety labs, fibrosis assessment, and surveillance for cirrhosis complications when needed.
Seek evaluation for unexplained abnormal liver tests, jaundice, dark urine, persistent fatigue with liver concerns, or known autoimmune disease. Confusion, bleeding, severe swelling, or fainting requires urgent care.
Autoimmune hepatitis can be silent, and no single antibody test confirms it. A structured liver evaluation can separate it from viral, metabolic, medication-related, and bile-duct diseases.
